about
The inflammatory protein Pentraxin 3 in cardiovascular diseaseVacuolar Protein Sorting Genes in Parkinson's Disease: A Re-appraisal of Mutations Detection Rate and Neurobiology of DiseaseAntitumor activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in mouse xenograft model of breast cancer.The role of norepinephrine in epilepsy: from the bench to the bedside.Neuronal inclusions in degenerative disorders Do they represent static features or a key to understand the dynamics of the disease?Compartment-dependent mitochondrial alterations in experimental ALS, the effects of mitophagy and mitochondriogenesisA hypothesis on prion disorders: are infectious, inherited, and sporadic causes so distinct?Genetic or pharmacological blockade of noradrenaline synthesis enhances the neurochemical, behavioral, and neurotoxic effects of methamphetamine.The Wnt antagonist, Dickkopf-1, as a target for the treatment of neurodegenerative disorders.Intermittent Dopaminergic stimulation causes behavioral sensitization in the addicted brain and parkinsonism.Histochemical approaches to assess cell-to-cell transmission of misfolded proteins in neurodegenerative diseases.The role of autophagy in epileptogenesis and in epilepsy-induced neuronal alterations.Brain diseases and tumorigenesis: The good and bad cops of pentraxin3.The Autophagoproteasome a Novel Cell Clearing Organelle in Baseline and Stimulated Conditions.The emerging role of m-TOR up-regulation in brain Astrocytoma.Rapamycin inhibits the growth of glioblastoma.Abnormal involuntary movements (AIMs) following pulsatile dopaminergic stimulation: severe deterioration and morphological correlates following the loss of locus coeruleus neurons.Pentraxin 3 Induces Vascular Endothelial Dysfunction Through a P-selectin/Matrix Metalloproteinase-1 Pathway.Hyperalgesic activity of kisspeptin in mice.Potentiation of mGlu5 receptors with the novel enhancer, VU0360172, reduces spontaneous absence seizures in WAG/Rij ratsAntitumour and antiangiogenic activities of [Pt(O,O'-acac)(γ-acac)(DMS)] in a xenograft model of human renal cell carcinoma.Plastic changes in the spinal cord in motor neuron diseaseProtective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1.Transglutaminase 2 ablation leads to defective function of mitochondrial respiratory complex I affecting neuronal vulnerability in experimental models of extrapyramidal disorders.Enhanced expression of the neuronal K+/Cl- cotransporter, KCC2, in spontaneously depressed Flinders Sensitive Line rats.mGLU3 metabotropic glutamate receptors modulate the differentiation of SVZ-derived neural stem cells towards the astrocytic lineage.Altered distribution and function of A2A adenosine receptors in the brain of WAG/Rij rats with genetic absence epilepsy, before and after appearance of the disease.Protective role for type-1 metabotropic glutamate receptors against spike and wave discharges in the WAG/Rij rat model of absence epilepsy.DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy).Endogenous activation of mGlu5 metabotropic glutamate receptors contributes to the development of nigro-striatal damage induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice.Loss of spinal motor neurons and alteration of alpha-synuclein immunostaining in MPTP induced Parkinsonism in mice.High number of striatal dopaminergic neurons during early postnatal development: correlation analysis with dopaminergic fibers.Occurrence of neuronal inclusions combined with increased nigral expression of alpha-synuclein within dopaminergic neurons following treatment with amphetamine derivatives in mice.Switch in the expression of mGlu1 and mGlu5 metabotropic glutamate receptors in the cerebellum of mice developing experimental autoimmune encephalomyelitis and in autoptic cerebellar samples from patients with multiple sclerosis.The preferential mGlu2/3 receptor antagonist, LY341495, reduces the frequency of spike-wave discharges in the WAG/Rij rat model of absence epilepsy.Activation of brain metabolism and fos during limbic seizures: the role of locus coeruleus.TGF-beta 1 protects against Abeta-neurotoxicity via the phosphatidylinositol-3-kinase pathway.Enhanced tau phosphorylation in the hippocampus of mice treated with 3,4-methylenedioxymethamphetamine ("Ecstasy").mTOR-Dependent Cell Proliferation in the Brain.
P50
Q26738957-CA27523E-A6D3-4ED2-A4F2-639E4A2BD155Q28074841-0C29BB93-81AC-4125-94DD-D14B3475EFADQ33695015-991D4D2D-AE04-45BD-8F40-A8490068DA8BQ35909385-FF9E54D1-5622-4779-B8D4-CF18B448DD15Q36089797-58A5064E-B2CB-472B-AC91-0A3FB5664B7FQ36254308-6C0BB939-478F-432B-ADDC-CB1A5FCFDFA5Q36419930-2E935463-F9B8-4414-801B-9EE12AE33C65Q37029888-E16E6EC3-6FA6-45C8-83FD-7ADEA539065CQ37144218-78FC997C-6E9B-4DD7-BC9C-BF78DF15F78DQ37629269-ED68EDEB-F76A-4F7B-A7EF-A1E71340B13BQ38095350-F2C39100-E156-4D01-BAC8-77DEBB860F0DQ38248845-341DB2E5-B3E1-41A9-AC65-B14B50B5545CQ38612312-60CBD2B5-8E38-4995-839E-1A0877CC5E0AQ38753705-423EBA7F-5E4A-44AA-A5FC-189AC13E7CD9Q38989360-ED15F2D7-AB13-457B-BAE0-3B55E9DD4F53Q39222056-F7D30DBD-2A21-4B94-BBFC-223AB1B67D51Q39341068-4447B8B5-F18A-45AC-B1D4-A279DDCB1047Q41276392-D71D9026-A593-497D-8E40-FD289F995DE6Q41439649-6443DECC-BF86-4B70-AA45-95CB84772864Q41849968-5C0F9772-BF38-45A2-A106-DFA93539B3EDQ41881241-9E738373-0295-41A8-918C-BB25E150729FQ42143912-85F470DC-094A-4275-A30E-CF86292FD7F3Q42166995-4BDDD85F-8EF8-44C4-B5F4-9C224DCD4910Q42264500-2D89714B-4C2A-4F99-B63D-6411C66E7AFAQ42503234-F8370843-C740-4ABF-930B-FD971058DA8FQ43162943-50732ED9-C8F9-4C39-9E5E-E928EA2A7020Q43187398-C722CE43-21C2-481C-981B-DBDCF10AE562Q43282432-9910B512-6FCB-4739-8064-137ED5234C5AQ43421668-496ED332-4FE3-48AB-B684-8C36528BC86BQ44691878-2982FFD0-75C9-40D8-8A1C-2FC4A2E592A5Q44746550-8B37F2CB-ADF6-4AB5-9573-83069CE94C67Q44904779-C7E6D89C-6258-4CA7-A4D9-14FF35902207Q46402614-763F65CA-4D27-4877-B9F4-0D1F760E565FQ46440075-5F13469D-9400-484D-88AE-C2382B2519C6Q46488583-48F4D43B-CC57-4ADC-8CA2-6B585A25B227Q46618223-57717289-3B57-42BE-BB78-9BF004B5F5E7Q46658978-5F660E9D-D1C4-4759-959A-ED528F9D7EA8Q46690418-55DC3FD4-77E2-48C2-B282-D7FC65AF5286Q46691801-07501567-9FA0-44A4-9A0E-4FBA40D43646Q47231432-21A595E3-E49D-4ED4-96C3-A2FA332E129A
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Francesca Biagioni
@ast
Francesca Biagioni
@en
Francesca Biagioni
@es
Francesca Biagioni
@nl
Francesca Biagioni
@sl
type
label
Francesca Biagioni
@ast
Francesca Biagioni
@en
Francesca Biagioni
@es
Francesca Biagioni
@nl
Francesca Biagioni
@sl
prefLabel
Francesca Biagioni
@ast
Francesca Biagioni
@en
Francesca Biagioni
@es
Francesca Biagioni
@nl
Francesca Biagioni
@sl
P1053
G-7979-2011
P106
P1153
8737355900
P21
P31
P3829
P496
0000-0003-3566-4889